vs
Esquire Financial Holdings, Inc.（ESQ）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Esquire Financial Holdings, Inc.的1.9倍（$75.5M vs $40.5M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 15.0%）
Esquire Financial Holdings是一家总部位于美国的银行控股公司，提供全面的商业及零售银行服务，核心业务包含存款账户、企业贷款、按揭服务及财富管理解决方案，主要服务中小型企业、法律行业从业者及当地零售客户。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
ESQ vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.9倍
$40.5M
两年增速更快
PBYI
近两年复合增速
15.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $40.5M | $75.5M |
| 净利润 | $12.2M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | — | 22.7% |
| 净利率 | 30.2% | — |
| 营收同比 | — | 27.7% |
| 净利润同比 | 7.0% | — |
| 每股收益（稀释后） | $1.40 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESQPBYI
| Q1 26 | $40.5M | — | ||
| Q4 25 | $39.4M | $75.5M | ||
| Q3 25 | $37.6M | $54.5M | ||
| Q2 25 | $35.8M | $52.4M | ||
| Q1 25 | $33.8M | $46.0M | ||
| Q4 24 | $33.1M | $59.1M | ||
| Q3 24 | $31.9M | $80.5M | ||
| Q2 24 | $30.6M | $47.1M |
净利润ESQPBYI
| Q1 26 | $12.2M | — | ||
| Q4 25 | $13.5M | — | ||
| Q3 25 | $14.1M | $8.8M | ||
| Q2 25 | $11.9M | $5.9M | ||
| Q1 25 | $11.4M | $3.0M | ||
| Q4 24 | $11.8M | — | ||
| Q3 24 | $11.4M | $20.3M | ||
| Q2 24 | $10.5M | $-4.5M |
毛利率ESQPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
营业利润率ESQPBYI
| Q1 26 | — | — | ||
| Q4 25 | 44.3% | 22.7% | ||
| Q3 25 | 46.5% | 17.6% | ||
| Q2 25 | 42.5% | 12.7% | ||
| Q1 25 | 45.9% | 8.7% | ||
| Q4 24 | 47.4% | 22.6% | ||
| Q3 24 | 48.8% | 27.4% | ||
| Q2 24 | 46.9% | -4.6% |
净利率ESQPBYI
| Q1 26 | 30.2% | — | ||
| Q4 25 | 34.2% | — | ||
| Q3 25 | 37.4% | 16.2% | ||
| Q2 25 | 33.2% | 11.2% | ||
| Q1 25 | 33.8% | 6.5% | ||
| Q4 24 | 35.6% | — | ||
| Q3 24 | 35.6% | 25.2% | ||
| Q2 24 | 34.3% | -9.6% |
每股收益（稀释后）ESQPBYI
| Q1 26 | $1.40 | — | ||
| Q4 25 | $1.54 | $0.26 | ||
| Q3 25 | $1.62 | $0.17 | ||
| Q2 25 | $1.38 | $0.12 | ||
| Q1 25 | $1.33 | $0.06 | ||
| Q4 24 | $1.35 | $0.40 | ||
| Q3 24 | $1.34 | $0.41 | ||
| Q2 24 | $1.25 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $222.2M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $301.3M | $130.3M |
| 总资产 | $2.4B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资ESQPBYI
| Q1 26 | $222.2M | — | ||
| Q4 25 | $235.9M | $97.5M | ||
| Q3 25 | $240.8M | $94.4M | ||
| Q2 25 | $163.0M | $96.0M | ||
| Q1 25 | $173.0M | $93.2M | ||
| Q4 24 | $126.3M | $101.0M | ||
| Q3 24 | $147.7M | $96.7M | ||
| Q2 24 | $152.7M | $96.8M |
总债务ESQPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M |
股东权益ESQPBYI
| Q1 26 | $301.3M | — | ||
| Q4 25 | $289.6M | $130.3M | ||
| Q3 25 | $279.2M | $115.3M | ||
| Q2 25 | $263.6M | $104.7M | ||
| Q1 25 | $250.7M | $97.1M | ||
| Q4 24 | $237.1M | $92.1M | ||
| Q3 24 | $232.6M | $71.1M | ||
| Q2 24 | $217.4M | $48.5M |
总资产ESQPBYI
| Q1 26 | $2.4B | — | ||
| Q4 25 | $2.4B | $216.3M | ||
| Q3 25 | $2.2B | $202.9M | ||
| Q2 25 | $2.1B | $194.9M | ||
| Q1 25 | $2.0B | $196.2M | ||
| Q4 24 | $1.9B | $213.3M | ||
| Q3 24 | $1.8B | $220.7M | ||
| Q2 24 | $1.7B | $205.0M |
负债/权益比ESQPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流ESQPBYI
| Q1 26 | — | — | ||
| Q4 25 | $59.8M | $14.4M | ||
| Q3 25 | $16.8M | $9.7M | ||
| Q2 25 | $10.5M | $14.1M | ||
| Q1 25 | $15.8M | $3.6M | ||
| Q4 24 | $42.2M | $15.6M | ||
| Q3 24 | $10.5M | $11.0M | ||
| Q2 24 | $7.2M | $1.0M |
自由现金流ESQPBYI
| Q1 26 | — | — | ||
| Q4 25 | $56.7M | $14.4M | ||
| Q3 25 | $16.2M | $9.7M | ||
| Q2 25 | $9.3M | $14.1M | ||
| Q1 25 | $14.7M | $3.6M | ||
| Q4 24 | $41.5M | $15.6M | ||
| Q3 24 | $10.5M | $11.0M | ||
| Q2 24 | $6.9M | $1.0M |
自由现金流率ESQPBYI
| Q1 26 | — | — | ||
| Q4 25 | 143.9% | 19.1% | ||
| Q3 25 | 43.2% | 17.7% | ||
| Q2 25 | 26.0% | 26.8% | ||
| Q1 25 | 43.4% | 7.7% | ||
| Q4 24 | 125.5% | 26.4% | ||
| Q3 24 | 32.8% | 13.7% | ||
| Q2 24 | 22.5% | 2.1% |
资本支出强度ESQPBYI
| Q1 26 | — | — | ||
| Q4 25 | 8.0% | 0.0% | ||
| Q3 25 | 1.3% | 0.0% | ||
| Q2 25 | 3.2% | 0.0% | ||
| Q1 25 | 3.4% | 0.1% | ||
| Q4 24 | 2.2% | 0.0% | ||
| Q3 24 | 0.2% | 0.0% | ||
| Q2 24 | 1.1% | 0.0% |
现金转化率ESQPBYI
| Q1 26 | — | — | ||
| Q4 25 | 4.44× | — | ||
| Q3 25 | 1.19× | 1.10× | ||
| Q2 25 | 0.88× | 2.41× | ||
| Q1 25 | 1.39× | 1.21× | ||
| Q4 24 | 3.59× | — | ||
| Q3 24 | 0.93× | 0.54× | ||
| Q2 24 | 0.69× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESQ
| Net Interest Income | $34.0M | 84% |
| Noninterest Income | $6.5M | 16% |
PBYI
暂无分部数据
